142 related articles for article (PubMed ID: 18981101)
1. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV.
Otten MA; van der Bij GJ; Verbeek SJ; Nimmerjahn F; Ravetch JV; Beelen RH; van de Winkel JG; van Egmond M
J Immunol; 2008 Nov; 181(10):6829-36. PubMed ID: 18981101
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice.
Boross P; Jansen JH; van Tetering G; Nederend M; Brandsma A; Meyer S; Torfs E; van den Ham HJ; Meulenbroek L; de Haij S; Leusen JH
Immunol Lett; 2014 Aug; 160(2):151-7. PubMed ID: 24613852
[TBL] [Abstract][Full Text] [Related]
3. IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice.
Hjelm F; Carlsson F; Verbeek S; Heyman B
Scand J Immunol; 2005 Nov; 62(5):453-61. PubMed ID: 16305642
[TBL] [Abstract][Full Text] [Related]
4. Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy.
van der Bij GJ; Bögels M; Otten MA; Oosterling SJ; Kuppen PJ; Meijer S; Beelen RH; van Egmond M
J Hepatol; 2010 Oct; 53(4):677-85. PubMed ID: 20619916
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic and cytostatic properties of an anti-human Fc gammaRI (CD64) x epidermal growth factor bispecific fusion protein.
Goldstein J; Graziano RF; Sundarapandiyan K; Somasundaram C; Deo YM
J Immunol; 1997 Jan; 158(2):872-9. PubMed ID: 8993006
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.
Albanesi M; Mancardi DA; Macdonald LE; Iannascoli B; Zitvogel L; Murphy AJ; Daëron M; Leusen JH; Bruhns P
J Immunol; 2012 Dec; 189(12):5513-7. PubMed ID: 23150715
[TBL] [Abstract][Full Text] [Related]
7. Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions.
Baudino L; Shinohara Y; Nimmerjahn F; Furukawa J; Nakata M; Martínez-Soria E; Petry F; Ravetch JV; Nishimura S; Izui S
J Immunol; 2008 Nov; 181(9):6664-9. PubMed ID: 18941257
[TBL] [Abstract][Full Text] [Related]
8. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity.
Gavin AL; Barnes N; Dijstelbloem HM; Hogarth PM
J Immunol; 1998 Jan; 160(1):20-3. PubMed ID: 9551950
[TBL] [Abstract][Full Text] [Related]
9. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
Keler T; Graziano RF; Mandal A; Wallace PK; Fisher J; Guyre PM; Fanger MW; Deo YM
Cancer Res; 1997 Sep; 57(18):4008-14. PubMed ID: 9307286
[TBL] [Abstract][Full Text] [Related]
10. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.
Dombrowicz D; Flamand V; Miyajima I; Ravetch JV; Galli SJ; Kinet JP
J Clin Invest; 1997 Mar; 99(5):915-25. PubMed ID: 9062349
[TBL] [Abstract][Full Text] [Related]
11. In vivo induction of functional Fc gammaRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF).
Michon JM; Gey A; Moutel S; Tartour E; Meresse V; Fridman W; Teillaud JL
Br J Haematol; 1998 Mar; 100(3):550-6. PubMed ID: 9504638
[TBL] [Abstract][Full Text] [Related]
12. The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma.
Bevaart L; Jansen MJ; van Vugt MJ; Verbeek JS; van de Winkel JG; Leusen JH
Cancer Res; 2006 Feb; 66(3):1261-4. PubMed ID: 16452176
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of Fc gammaRI on primary sensory neurons increases insulin-like growth factor-I production, thereby reducing reperfusion-induced renal injury in mice.
Harada N; Zhao J; Kurihara H; Nakagata N; Okajima K
J Immunol; 2010 Jul; 185(2):1303-10. PubMed ID: 20548031
[TBL] [Abstract][Full Text] [Related]
14. Responses of neutrophils to anti-integrin antibodies depends on costimulation through low affinity Fc gamma Rs: full activation requires both integrin and nonintegrin signals.
Jakus Z; Berton G; Ligeti E; Lowell CA; Mócsai A
J Immunol; 2004 Aug; 173(3):2068-77. PubMed ID: 15265942
[TBL] [Abstract][Full Text] [Related]
15. Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity.
Bevaart L; Goldstein J; Vitale L; Russoniello C; Treml J; Zhang J; Graziano RF; Leusen JH; van de Winkel JG; Keler T
Br J Haematol; 2006 Feb; 132(3):317-25. PubMed ID: 16409296
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus induces an Fc gamma receptor (Fc gammaR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc gammaRs.
MacCormac LP; Grundy JE
J Infect Dis; 1996 Dec; 174(6):1151-61. PubMed ID: 8940203
[TBL] [Abstract][Full Text] [Related]
17. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.
Strait RT; Morris SC; Finkelman FD
J Clin Invest; 2006 Mar; 116(3):833-41. PubMed ID: 16498503
[TBL] [Abstract][Full Text] [Related]
18. Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells.
Tan PS; Gavin AL; Barnes N; Sears DW; Vremec D; Shortman K; Amigorena S; Mottram PL; Hogarth PM
J Immunol; 2003 Mar; 170(5):2549-56. PubMed ID: 12594281
[TBL] [Abstract][Full Text] [Related]
19. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
Braster R; Grewal S; Visser R; Einarsdottir HK; van Egmond M; Vidarsson G; Bögels M
PLoS One; 2017; 12(5):e0177736. PubMed ID: 28542406
[TBL] [Abstract][Full Text] [Related]
20. Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects.
Schiff DE; Rae J; Martin TR; Davis BH; Curnutte JT
Blood; 1997 Oct; 90(8):3187-94. PubMed ID: 9376602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
